MDS 2023
Published by:
THE MYELODYSPLASTIC SYNDROMES FOUNDATION
Description
MDS 2023 | 17th International Congress on Myelodysplastic Syndromes Official App. Use this app to:
- Get information about the event, such as speakers and program
- Give feedback
- Receive important notifications from the organization
- Interact with other participants
- Get information about the event, such as speakers and program
- Give feedback
- Receive important notifications from the organization
- Interact with other participants
Screenshots
MDS 2023 FAQ
-
Is MDS 2023 free?
Yes, MDS 2023 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is MDS 2023 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does MDS 2023 cost?
MDS 2023 is free.
-
What is MDS 2023 revenue?
To get estimated revenue of MDS 2023 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Egypt yet.
Ratings History
MDS 2023 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
MDS 2023 Installs
Last 30 days
MDS 2023 Revenue
Last 30 daysMDS 2023 Revenue and Downloads
Gain valuable insights into MDS 2023 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- THE MYELODYSPLASTIC SYNDROMES FOUNDATION
- Languages
- English, French, Dutch, German, Portuguese, Italian
- Recent release
- 1.2 (2 years ago )
- Released on
- Apr 7, 2023 (2 years ago )
- Also available in
- United States, Peru, South Africa, Chile, Saudi Arabia, India, Algeria, Australia, Israel, New Zealand, Argentina, Sweden, Portugal, Romania, Germany, Egypt, South Korea, Philippines, United Kingdom, China, Slovenia, Poland, Belarus, Japan, Türkiye, Netherlands, Greece
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.